Question 1

Will Anesloop disrupt our existing ASC IT stack?

Accepted Answer

No. Anesloop is designed to sit around the systems you already use, not replace your EHR, AIMS, or ASC management platform. The pilot starts with a scoped, read-only connection to the relevant feeds, so your chart of record, permissions, and downstream systems remain unchanged while the team evaluates the screening and reconciliation workflows.

Question 2

Will Anesloop add work for our anesthesia staff?

Accepted Answer

The intent is to reduce duplicate review, not create another queue. Anesloop surfaces exceptions and drafts the work from the information already available, while the anesthesia team makes the clinical decision, confirms the controlled-substance record, or sends an item back; the pilot measures minutes saved and exception volume alongside acceptance and accuracy so the workflow earns its place.

Question 3

Will this conflict with our EHR’s existing pre-op screening?

Accepted Answer

Anesloop does not become a second chart of record or silently overwrite the EHR. It reviews the agreed pre-op data set, identifies missing or clinically relevant items for the anesthesia team, and keeps its recommendation separate until an authorized clinician accepts or edits it; the pilot defines the handoff points with your medical director before anything is put into routine use.

Question 4

Will narcotics reconciliation hold up under an ASCA or AAAHC survey?

Accepted Answer

Anesloop is built to make the reconciliation trail easier to review, not to substitute for your policies or surveyor guidance. Each draft can carry the case, lot, witness, wastage, user, and timestamp details your team records, with edits and sign-offs preserved for an exportable audit trail; your compliance lead and medical director still approve the workflow against current ASCA, AAAHC, state, and facility requirements.

Question 5

How quickly should we expect to see ROI?

Accepted Answer

The 30-day founding pilot is designed to answer that with your own baseline rather than a generic promise. Week one establishes screening and reconciliation time, exception volume, and variance; the remaining weeks compare those measures with clinician acceptance and audit completeness, so by day 30 you have a practical go/no-go decision on whether the recovered staff time and reduced rework justify continuing.

Five questions ASC admins and medical directors ask before they sign.

Join the next pilot cohort.